- Home
- China
- World
- Europe
- Politics
- Business
- Opinions
- Tech & Sci
- Culture
- Sports
- Travel
- Nature
- Picture
- Video
- Live
- TV
- Specials
Video
18:46, 08-Jun-2020
COVID-19 neutralizing antibody in phase-1 clinical trial in Shanghai
Share
Copied
01:19
A recombinant, fully human, monoclonal neutralizing antibody against COVID-19 entered the phase-1 clinical trial as it was injected into the first subject on Sunday in Shanghai. The clinical trial of the antibody was approved by the National Medical Products Administration on Friday.